A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform
A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform